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Abstract
Background: The cell membrane is a primary and fundamental player in most cellular processes, and fatty acids
form a major structural component of cell membranes. The aim of this study was to compare the membrane fatty
acid profiles of different human blood leukocytes and selected cell lines, to identify the effects of in vitro culture on
fatty acid profiles, and to test medium supplements for their effect on fatty acid profiles.
Methods: Different classes of leukocytes were isolated from human blood and their membrane fatty acid profiles
were analysed and compared. After culturing in vitro immortalised and primary leukocytes, membrane fatty acids
were analysed and compared. Finally, different lipid formulations were developed and used for supplementing
leukocytes in vitro in an effort to maintain the in vivo fatty acid profile. Descriptive and analytical tests were
performed to compare the obtained fatty acid profiles.
Results: Membrane fatty acid profiles of primary human CD4+ T-lymphocytes, CD8+ T-lymphocytes, B-lymphocytes
and monocytes differed. Moreover, there were differences among Jurkat, Raji and THP-1 cell lines and the
corresponding primary leukocyte classes, as well as between freshly prepared and in vitro cultured primary
lymphocytes. A lipid supplement was able to maintain cultured Jurkat cells with a membrane fatty acid
profile almost identical to that of the primary CD4+ T-lymphocytes. Finally, variations in the lipid supplement
composition enabled the development of Jurkat cells with different membrane fatty acid profiles characterising
different physiological or pathological human conditions.
Conclusions: Each leukocyte class has its own specific membrane fatty acid profile in vivo. Cultured primary
leukocytes and immortalized leukocytic cells display different membrane fatty acid profiles when compared to
their respective in vivo counterparts. The membrane fatty acid composition of cultured cells can be restored to
reflect that of the corresponding in vivo condition through use of optimised lipid supplementation. Typical
physiological or pathological leukocyte membrane fatty acid profiles can be obtained by tuning in vitro fatty acid
supplementation.
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Background
The plasma membrane of cells provides a physical
barrier separating the contents of a cell from its sur-
roundings, but allowing for specific communication with
the extracellular environment through receptors, trans-
porters and so on and for the generation of intracellular
signals that are key to cellular responsiveness. The lipid
composition of the plasma membrane has long been rec-
ognized to be important in creating the environment in
which membrane proteins can function [1] and in
providing the substrates from which many second mes-
sengers are generated [2]. More recent studies have
identified membrane lipid rafts as vital functional com-
ponents of cellular responses [3–5] and membrane lipids
as being responsible for coordinating many core aspects
of cell metabolism [6–8]. Among the many lipid species
characterising cell membranes, fatty acids are the pre-
dominant structural component and can constitute up
to 80 % in weight of the lipid part of the membrane. Cell
membrane fatty acids are typically 14 to 24 carbons in
length and contain between 0 and 6 double bonds, these
structural characteristics strongly influencing the bio-
physical and functional properties of the membrane
[9, 10]. Taken individually or in bulk, membrane fatty
acids influence fundamental properties of the cell,
such as membrane fluidity [6, 11], protein folding and
functionality [12], lipid rafts and signalling [13–15],
and trafficking processes [16, 17], among others. As
an example, many of the functional effects of fatty
acids on inflammation and immunity relate to the in-
corporation of the fatty acids into the membranes of
the cells involved in those processes from where they
exert their effects [18, 19].
The function of cells is often examined in culture sys-
tems using either primary cells isolated from humans or
experimental animals or using immortalised cell lines.
Despite the widespread use of cell cultures, this ap-
proach suffers from high variability and technical limita-
tions, perhaps made worse by the use of animal-derived
components and non-standardised sera. Even the im-
pressive recent technological advances, such as 3D cul-
tures and Body-on-Chips, do not allow current models
to be completely reliable, with many variables still not
considered. At present, cell culture technology is far
from being a completely predictable experimental model
able to reproduce in vivo cell physiology and behaviour;
this variance leads to scientific data and pre-clinical
studies which often are unreliable and misleading. In
particular, despite its proven importance, membrane
lipid content, composition and behaviour are poorly
considered during cell culture. Furthermore, due to sig-
nificant alterations of the fatty acid content and compos-
ition of the cell membrane, and consequently also of its
biophysical and functional properties, during culture
cells differ greatly from their corresponding in vivo com-
parators [20, 21]. This introduces substantial biases in
most in vitro studies, with serious consequences for the
reliability of experimental data, weakening the usefulness
of in vitro research and resulting in significant waste of
time and resources.
The fatty acid composition of leukocytes has been
widely reported and linked to the ability of specific
fatty acids to influence immune and inflammatory re-
sponses [19, 22–24]. In fact, leukocytes have a spe-
cific fatty acid profile, which differs amongst different
leukocyte classes and is finely tuned in time and
space for their specific functions [25–27]. In addition,
the fatty acid composition of the leukocyte membrane
is subject to significant variations deriving from indi-
vidual dietary habits [28]. These aspects are not taken
into account in current cell culture approaches, and
this causes in vitro studies to be often unreliable and
misleading.
The objective of the current study was to expand our
knowledge of membrane fatty acid composition of pri-
mary human leukocyte classes, the influence of cell cul-
ture on such composition, and how primary leukocytes
compare with immortalised leukocyte-derived cell lines.
To our knowledge, this is the first study addressing this
intriguing issue. Our pre-study hypothesis was that
cultured leukocytes will differ in membrane fatty acid
composition from the corresponding primary leuko-
cytes, thus highlighting the importance of a correct
ad-hoc in vitro supplementation to create culture condi-




Peripheral blood mononuclear cells (PBMCs) were ob-
tained from buffy coat preparations derived from the
whole blood of 8 healthy male donors anonymously
identified by code numbers (mean age 48.5 ± 13.4 years).
Buffy coats no more available for clinical use (not
used within 24 h after collection) were provided by
the Transfusion Unit of the Ospedale Maggiore (Bologna)
as approved by the Centro Regionale Sangue (Prot.
N.32041/10-14-01).
Mononuclear cell isolation and CD14+, CD8+, CD19+ and
CD4+ cell purification
PBMCs were isolated by conventional density gradient
centrifugation over Lympholyte-H gradient medium
(ρ = 1.077 ± 0.001 g/cm3; Cedarlane, USA). Briefly,
buffy coats were diluted with 3 volumes of PBS and
layered over Lympholyte-H (at a 2:1 ratio) in 50 ml
conical tubes, then centrifuged at 800 × g for 20 min
at room temperature. PBMCs collected at the interphase
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were washed twice with PBS (400 × g for 10 min), counted
and resuspended in PBS containing 0.5 % fatty acid-free
bovine serum albumin (GE Healthcare, Milan, Italy) and
2 mM EDTA, pH 8.0. PBMCs were then immediately used
for purification of cellular subpopulations.
CD14+, CD19+ and CD8+ cellular subpopulations were
purified using an AutoMACS Pro Separator (Miltenyi
Biotec, Bologna, Italy) and specific microbeads for
positive selection (CD14, CD19 and CD8 Microbeads;
Miltenyi Biotec, Bologna, Italy). The CD4+ cell popu-
lation was positively purified from the CD14 negative
eluted fraction with the same instrument and CD4
Microbeads (Miltenyi Biotec, Bologna, Italy). MACS
isolated cell subsets were collected, counted and an
aliquot of those subsets was used to assess population
purity. Cells were incubated for 15 min at room
temperature with FITC-conjugated antibodies against
CD14, CD19, CD8 and CD4 (Miltenyi Biotec, Bologna,
Italy), washed twice in PBS and evaluated by flow cytome-
try (FACSCanto II, BD). FITC fluorescence was filtered by
a 530 ± 21 bandpass filter. The frequency of positive cells
was measured as the percentage of gated cells in the
FITC channel with activities above 99 % of the corre-
sponding isotype control. Purities of the obtained cell
populations were (mean ± SD): 91.9 ± 3.7 % for CD14+,
93.8 ± 6.9 % for CD19+, 92.4 ± 4.4 % for CD8+ and
94.9 ± 3.7 % for CD4+. Freshly isolated cell populations
were washed, lysed and pelleted as described below.
In vitro cultures
All cell culture media, sera and reagents were purchased
from Euroclone SpA, Milan, Italy. Immortalised
leukocytic cell lines (Jurkat, Raji and THP-1 cells) were
kindly provided by Rizzoli Orthopedic Institute and
University of Bologna. Jurkat, Raji and THP-1 cells
were cultured in RPMI-1640 medium containing 10 %
fetal bovine serum (FBS), L-glutamine (2 mM), peni-
cillin (100 U/ml), and streptomycin (100 μg/ml). Cells
were maintained in a humidified environment at 37 °C
and 5 % CO2 and cultured in polystyrene culture flasks.
Cells were passaged every 3 days, thus maintaining cell
number between 1 × 105 and 1 × 106 per ml of medium
(Jurkat cells), between 4 × 105 and 3 × 106 per ml of
medium (Raji cells), or between 2 × 105 and 1 × 106 per ml
of medium (THP-1 cells), according to the standard
protocol provided by the American Type Culture
Collection (ATCC).
To compare freshly isolated healthy human lympho-
cytes with primary cultured lymphocytes, PBMCs were
isolated from the buffy coat of a 40 year old healthy
male donor on a density gradient, as described above.
Cells recovered from the gradient interphase were
washed in PBS, resuspended in RPMI supplemented
with 10 % FBS, counted and seeded in flasks at a density
of 2 × 106 cells/ml for 3 h to allow monocyte adher-
ence. After this time, lymphocytes were recovered and
maintained in culture in RPMI-1640 medium supple-
mented with 10 % FBS for 96 h in the absence or
presence of 20 μg/ml phytohaemagglutinin (PHA) and
then recovered. Freshly isolated and 96-h cultured
lymphocytes were washed, lysed and pelleted as de-
scribed below.
Membrane isolation
Cells (7 × 106) were collected in a 15 ml tube, centri-
fuged at 500 × g for 5 min and resuspended in 10 ml of
PBS. The wash was repeated five times in order to dis-
card traces of medium and serum used during the cul-
ture process. Cells were then resuspended into 500 μl of
PBS and collected in a 1 ml tube, to which 500 μl of
sterile H2O were added. Cells were then centrifuged for
30 min at 15,000 × g in a refrigerated centrifuge at 4 °C.
The collected membranes were resuspended in 1 ml of
PBS:H2O 1:1 and washed 5 times following the same
procedure.
Fatty acid composition analysis
Cell and cell membrane lipids were extracted with
CHCl3/MeOH 2:1 (vol/vol) and then incubated with
0.5 M KOH in methanol for 10 min at room
temperature, thus trans-esterifying fatty acids linked
by ester bonds to alcohols. The corresponding fatty
acid methyl esters (FAMEs) were formed, extracted
with n-hexane and separated by gas chromatography.
FAMEs were separated by gas-chromatography in an
Agilent 7820A GC System (Agilent Technologies,
Santa Clara, USA) fitted with a 30 m × 0.32 mm
DB23 capillary column, film thickness 0.25 μm, and a
Flame Ionization Detector (FID). Helium was used as
carrier gas at 2.54 ml/min and the spilt injector was
used with a split ratio of 10:1. Injector temperature
was 250 °C and detector temperature was 260 °C.
The column oven temperature was maintained at 50 °C
for 2 min after sample injection and was programmed for
the following temperature gradient: 10 °C/min from 50 °C
to 180 °C, 3 °C/min from 180 °C to 200 °C and hold-
ing at 200 °C for 6 min. The separation was recorded
with G6714AA SW EZChrom Elite Compact (Agilent
Technologies). FAMEs were identified by comparison
with standards purchased from NuCheckPrep Inc.,
Elysian, USA. FAMEs are expressed in weight %,
based upon the % contribution of the peak area of
each FAME in the chromatogram. To take into ac-
count the different signal of the detector for different
molecules, a correction factor was applied to the ex-
perimental data coming from the integration of the
chromatograms. The total of the peaks analysed for
each chromatographic run was 100.
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Fatty acid aggregates were calculated as follows:
Ʃ SFA = 14:0 + 15:0 + 16:0 + 17:0 + 18:0 + 20:0 + 22:0 +
23:0 + 24:0;
Ʃ MUFA= 16:1n-7 + 18:1n-9 + 18:1n-7 + 20:1n-9 + 22:1n-
9 + 24:1n-9;
Ʃ PUFA= 18:2n-6 + 18:3n-6 + 18:3n-3 + 20:3n-9 + 20:3n-
6 + 20:4n-6 + 20:3n-3 + 20:5n-3 + 22:2n-6 + 22:4n-6 + 22:5n-
6 + 22:5n-3 + 22:6n-3;
Ʃ trans FA = t16:1n-7 + t18:1n-9;
Ʃ Omega3 = 18:3n-3 + 20:3n-3 + 20:5n-3 + 22:5n-3 +
22:6n-3;
Ʃ Omega6 = 18:2n-6 + 18:3n-6 + 20:3n-6 + 20:4n-6 +
22:2n-6 + 22:4n-6 + 22:5n-6;
Ʃ Omega7 = 16:1n-7 + 18:1n-7;
Ʃ Omega9 = 18:1n-9 + 20:1n-9 + 22:1n-9 + 24:1n-9.
Indexes were calculated as follows:
Unsaturation Index (UI) = Ʃ [mi*ni], where mi =mole
percentage, ni = n° of double bonds;
Peroxidability Index (PI) = Ʃ monoenoic*0.025 + Ʃ
dienoic + Ʃ trienoic*2 + Ʃ tetraenoic*3 + Ʃ pentaenoic*6 + Ʃ
hexaenoic*8.
Refeed® supplements
Refeed® supplements (Remembrane Srl, Imola, Italy) are
a completely defined combination of non-animal derived
lipids and antioxidants (NuCheckPrep Inc., Elysian,
USA; Sigma Aldrich, St. Louis, USA; Applichem an ITW
Inc., Chicago, USA) solubilised in 1 ml of ethanol (Sigma
Aldrich). 1 ml of Refeed® was diluted in 560 ml of
complete cell growth medium, the resulting ethanol con-
centration being < 1 % (vol/vol) in the final medium.
Refeed® WT (Wild-Type), Refeed® CVD (Cardiovascular
Disease) and Refeed® O3+ (Omega-3 plus) were specific-
ally developed for Jurkat cells and their compositions are
shown in Table 1.
Statistical analysis
Descriptive and analytical tests were performed with
IBM SPSS® Statistics, Version 21.0. Data were checked
for normality using the Shapiro-Wilk normality test.
Normally distributed data were compared using
Student’s t-test, to determine if two sets of fatty acid data
were significantly different from each other. Non-
normally distributed data were compared using the
Mann–Whitney U-test. For sums and other aggregates
(UI, PI), Student's t-test was performed when the aggre-
gate was composed of all normally distributed individual
FAMEs, while Mann–Whitney U-test was performed
when the aggregate was composed of one or more not
normally distributed FAMEs. For each test, the signifi-
cance threshold was P < 0.05.
Results
Primary leukocyte classes have different membrane fatty
acid compositions from one another
From the blood of 8 healthy individuals, four categories
of leukocytes were isolated: CD4+ T-lymphocytes (helper
T cells), CD8+ T-lymphocytes (cytotoxic T cells), CD19+
(B-lymphocytes) and CD14+ (monocytes). Their mem-
brane fatty acid compositions are reported in Table 2.
Data show a number of significant differences among
leukocyte classes, spread among individual fatty acids,
fatty acid sums and indexes. The five most prevalent
fatty acids in all four cell types were palmitic (16:0),
stearic (18:0), arachidonic (20:4n-6), oleic (18:1n-9) and
linoleic (18:2n-6), typically in that order. Among those
five fatty acids monocytes had the lowest proportions of
palmitic and stearic and the highest proportions of
oleic and arachidonic (Table 2). Docosahexaenoic acid
(22:6n-3) was present in all cell types at about 2 to
3 % by weight of total fatty acids (Table 2). As a re-
sult of the differences in individual fatty acids, the
sum of fatty acids of different classes differed among
the cell types (Table 2). In particular monocytes had
a lower proportion of saturated fatty acids and higher
proportions of monounsaturated fatty acids, PUFAs
and n-6 PUFAs (Table 2). Furthermore monocytes
had higher UI and PI, reflecting the higher PUFA
content (Table 2). The total n-6 to n-3 PUFA ratio
among the different cell types was around 5.
Immortalised leukocyte cell lines have different
membrane fatty acid compositions from one another
Three of the most common leukocytic cell lines used
in research, corresponding to the categories of leuko-
cytes described in Table 2, were selected for study.
Jurkat (T-lymphocytes), Raji (B-lymphocytes), THP-1
(monocytes) cells were cultivated in vitro following
the standard protocol provided by ATCC. The fatty
acid compositions of these cells are shown in Table 3.
Membrane fatty acid profiles were rather homoge-
neous among the three immortalised cell lines, being
characterised by significant proportions of palmitic,
stearic and oleic acids and rather low proportions of
PUFAs, in particular of n-6 PUFAs, and especially of
arachidonic acid (Table 3). The proportions of palmi-
toleic acid (16:1n-7) and 18:1n-7 were high (Table 3).
Overall, these cell lines displayed low values for UI
and PI.
Table 1 Composition of supplements used in the study
Refeed WT Refeed CVD Refeed O3+
Lipids 19.50 19.00 18.10
Antioxidants 5.35 0.48 7.48
Composition of Refeed® WT, Refeed® CVD, Refeed® O3+ used for in-vitro
supplementation of Jurkat cells. Data are the amount (mg) per 561 ml of
complete medium
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Table 2 Membrane fatty acid profiles of primary human leukocytes
CD4+ CD8+ CD19+ CD14+
14:0 0,635 ± 0,190abc 0,869 ± 0,185ae 0,923 ± 0,215bf 0,413 ± 0,157cef
15:0 0,256 ± 0,150abc 0,412 ± 0,125ae 0,430 ± 0,139bf 0,180 ± 0,107cef
16:0 27,156 ± 1,864abc 29,451 ± 2,352ade 31,780 ± 3,523bdf 20,373 ± 2,321cef
t16:1n-7 0,265 ± 0,133 0,364 ± 0,156 0,397 ± 0,171 0,203 ± 0,097
16:1n-7 0,257 ± 0,140 0,341 ± 0,161 0,358 ± 0,174 0,255 ± 0,080
17:0 0,696 ± 0,169c 0,922 ± 0,258e 0,879 ± 0,210f 0,435 ± 0,067cef
18:0 26,877 ± 3,827 28,296 ± 3,344e 30,470 ± 4,447f 24,146 ± 2,354ef
t18:1n-9 0,012 ± 0,033 0,021 ± 0,060 0,020 ± 0,057 0,039 ± 0,063
18:1n-9 7,919 ± 1,053abc 6,383 ± 1,044ae 7,083 ± 3,024bf 14,440 ± 1,039cef
18:1n-7 2,208 ± 0,375abc 1,662 ± 0,424a 1,431 ± 0,199b 1,552 ± 0,225c
18:2n-6 6,946 ± 1,323ab 5,071 ± 0,803ae 4,705 ± 0,878bf 6,577 ± 0,772ef
18:3n-6 0,179 ± 0,118 0,229 ± 0,138 0,206 ± 0,183 0,167 ± 0,091
18:3n-3 0,396 ± 0,319 0,601 ± 0,232e 0,536 ± 0,280f 0,180 ± 0,090ef
20:0 0,697 ± 0,241ab 1,096 ± 0,241ae 1,156 ± 0,215bf 0,533 ± 0,109ef
20:1n-9 0,806 ± 0,475 1,141 ± 0,995 0,896 ± 0,846 0,672 ± 0,249
20:3n-9 0,765 ± 0,090abc 0,513 ± 0,116a 0,608 ± 0,132b 0,618 ± 0,087c
20:3n-6 1,519 ± 0,396b 1,009 ± 0,332 0,899 ± 0,318bf 1,357 ± 0,304f
20:4n-6 12,755 ± 2,656bc 9,251 ± 3,097e 8,240 ± 4,173bf 16,422 ± 2,357cef
20:3n-3 0,041 ± 0,076 0,059 ± 0,119 0,000 ± 0,000 0,025 ± 0,059
20:5n-3 0,098 ± 0,112 0,166 ± 0,301 0,113 ± 0,165 0,138 ± 0,100
22:0 0,978 ± 0,579abc 1,642 ± 0,591ae 1,356 ± 0,435bf 0,492 ± 0,152cef
22:1n-9 1,588 ± 0,595 2,725 ± 1,570e 2,014 ± 1,418f 0,664 ± 0,430cef
22:2n-6 0,000 ± 0,000 0,024 ± 0,067 0,000 ± 0,000 0,031 ± 0,045
23:0 0,216 ± 0,277 0,239 ± 0,250 0,087 ± 0,175 0,057 ± 0,053
22:4n-6 1,816 ± 0,314c 2,662 ± 1,945e 1,545 ± 0,610f 3,553 ± 0,446cef
22:5n-6 0,356 ± 0,110c 0,234 ± 0,189e 0,431 ± 0,754 0,624 ± 0,227ce
22:5n-3 1,300 ± 0,444abc 0,855 ± 0,315ae 0,726 ± 0,279bf 2,376 ± 0,445cef
24:0 0,557 ± 0,345 0,809 ± 0,737e 0,606 ± 0,292 0,307 ± 0,135e
22:6n-3 2,672 ± 1,315 2,852 ± 2,253 2,040 ± 1,799 3,050 ± 1,187
24:1n-9 0,035 ± 0,098 0,098 ± 0,276 0,064 ± 0,180 0,123 ± 0,149
Ʃ SFA 58,067 ± 5,419bc 63,738 ± 5,544e 67,687 ± 7,719bf 46,936 ± 4,789cef
Ʃ MUFA 12,812 ± 1,675c 12,351 ± 2,609e 11,846 ± 3,172f 17,705 ± 1,311cef
Ʃ PUFA 28,844 ± 4,890bc 23,526 ± 4,114de 20,049 ± 5,101bdf 35,118 ± 3,867cef
Ʃ trans FA 0,276 ± 0,125 0,385 ± 0,135 0,417 ± 0,172 0,241 ± 0,100
Ʃ Omega3 4,507 ± 1,587 4,533 ± 2,154 3,415 ± 1,870f 5,770 ± 1,552f
Ʃ Omega6 23,572 ± 4,204b 18,481 ± 4,052e 16,026 ± 5,418bf 28,730 ± 3,304ef
Ʃ Omega7 2,465 ± 0,376bc 2,004 ± 0,477 1,789 ± 0,313b 1,806 ± 0,291c
Ʃ Omega9 11,112 ± 1,515c 10,861 ± 2,450e 10,665 ± 3,083f 16,516 ± 1,116cef
UI 109,691 ± 17,760bc 92,754 ± 17,734e 78,864 ± 20,728bf 141,417 ± 15,994cef
PI 91,565 ± 17,034c 79,091 ± 19,319e 65,462 ± 16,533f 118,882 ± 15,487cef
Membrane fatty acid profiles of different populations of primary human leukocytes (CD4+, CD8+, CD14+, CD19+). Data are expressed as mean (± SD) weight % of
total membrane fatty acids (n = 8). a, b, c, d, e, f Statistically significant difference (P < 0.05) as follows: a CD4+ vs CD8+, b CD4+ vs CD19+, c CD4+ vs CD14+, d CD8+ vs
CD19+, e CD8+ vs CD14+, f CD19+ vs CD14+
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Primary leukocyte classes have different membrane fatty
acid compositions from their corresponding immortalised
cell lines
Table 4 compares the fatty acid compositions of primary
human leukocytes and their corresponding immortalised
cell lines; these data are the same as those shown in
Tables 2 and 3. The comparisons are: CD4+ and CD8+ T
lymphocytes against Jurkat, CD19+ against Raji, and
CD14+ against THP-1. These data clearly demonstrate
that significant differences exist between the membrane
fatty acid profiles of in vitro cell lines and those of the
corresponding primary leukocytes, considering both in-
dividual fatty acids and fatty acid sums and indexes. Pal-
mitic acid was higher in B lymphocytes (CD19+ cells)
than in Raji cells and was lower in monocytes (CD14+
cells) than THP-1 cells. The cell lines had much higher
proportions of palmitoleic acid, 18:1n-7 and oleic acid
than primary human leukocytes. Conversely, the cell
lines had lower proportions of stearic, linoleic and ara-
chidonic acids. Interestingly docosahexaenoic acid was
fairly similar between cell lines and primary leukocytes.
Overall the cell lines had lower proportions of saturated
fatty acids and especially PUFAs, particularly n-6 PUFAs,
and higher proportions of monounsaturated fatty acids
(Table 4). Consequently UI and PI values were lower for
cell lines compared with primary leukocytes.
Cultured primary lymphocytes have different membrane
fatty acid compositions from their primary leukocyte
counterparts
The effect of culturing primary human lymphocytes on
their membrane fatty acid composition was investigated;
results are shown in Table 5. The culture period was
96 h, and cells were cultured either non-stimulated or
stimulated with the mitogen PHA. Cultured lymphocytes
show an altered membrane fatty acid profile when com-
pared with freshly isolated ones (Table 5). In particular,
membranes of cultured lymphocytes were characterized
by lower proportions of oleic acid, monounsaturated
fatty acids and PUFAs. Conversely membranes of freshly
isolated lymphocytes had higher proportions of palmitic,
stearic and total saturated fatty acids. Stimulating the
lymphocytes with the mitogen PHA had only modest ef-
fects on membrane fatty acid composition beyond those
seen with culture itself, except that the proportion of
Table 3 Membrane fatty acid profiles of Jurkat, Raji and THP-1
cell lines
Jurkat Raji THP-1
9:0 0,000 ± 0,000 0,046 ± 0,046 0,028 ± 0,062
12:0 0,056 ± 0,011 0,052 ± 0,015 0,062 ± 0,013
14:0 2,062 ± 0,085ab 1,647 ± 0,093ac 2,876 ± 0,064bc
14:1n-5 0,047 ± 0,028 0,000 ± 0,000c 0,062 ± 0,006c
15:0 0,194 ± 0,012ab 0,526 ± 0,074ac 0,332 ± 0,013bc
16:0 25,776 ± 2,014b 23,959 ± 1,124c 28,740 ± 0,998bc
t16:1n-7 0,834 ± 0,036ab 1,345 ± 0,108ac 2,138 ± 0,022bc
16:1n-7 7,188 ± 0,407ab 1,656 ± 0,085ac 5,331 ± 0,221bc
17:0 0,411 ± 0,050a 0,679 ± 0,071ac 0,452 ± 0,013c
17:1n-7 0,000 ± 0,000ab 0,695 ± 0,05ac 0,410 ± 0,014bc
18:0 18,049 ± 0,606ab 20,329 ± 0,837ac 16,379 ± 1,056bc
t18:1n-9 0,735 ± 0,033ab 0,000 ± 0,000a 0,000 ± 0,000b
18:1n-9 24,938 ± 1,156ab 20,063 ± 0,945a 22,013 ± 0,585b
18:1n-7 5,521 ± 0,356ab 8,007 ± 0,437ac 6,932 ± 0,205bc
18:2n-6 3,144 ± 0,210ab 3,893 ± 0,115ac 1,499 ± 0,053bc
18:3n-6 0,094 ± 0,017ab 0,045 ± 0,013a 0,042 ± 0,007b
18:3n-3 0,302 ± 0,036b 0,324 ± 0,05c 0,124 ± 0,017bc
20:0 0,608 ± 0,045ab 0,421 ± 0,037ac 0,476 ± 0,014bc
20:1n-9 0,942 ± 0,091ab 2,334 ± 0,091ac 0,469 ± 0,010bc
20:3n-9 0,302 ± 0,012ab 0,635 ± 0,066ac 1,005 ± 0,039bc
20:3n-6 0,108 ± 0,007ab 1,222 ± 0,042ac 0,983 ± 0,069bc
20:4n-6 2,166 ± 0,109ab 4,347 ± 0,511ac 3,501 ± 0,122bc
20:3n-3 0,000 ± 0,000ab 0,097 ± 0,013a 0,094 ± 0,006b
20:5n-3 0,042 ± 0,013ab 0,572 ± 0,038ac 0,509 ± 0,018bc
22:0 0,946 ± 0,114ab 0,409 ± 0,018ac 0,455 ± 0,034bc
22:1n-9 0,144 ± 0,018ab 0,223 ± 0,024ac 0,052 ± 0,006bc
22:2n-6 0,000 ± 0,000ab 0,117 ± 0,018ac 0,077 ± 0,005bc
23:0 0,056 ± 0,013 0,089 ± 0,015c 0,040 ± 0,007c
22:4n-6 0,747 ± 0,103b 0,684 ± 0,092c 0,231 ± 0,031bc
22:5n-6 0,164 ± 0,026b 0,216 ± 0,034 0,252 ± 0,020b
22:5n-3 1,074 ± 0,121ab 1,723 ± 0,069ac 1,364 ± 0,038bc
24:0 0,000 ± 0,000a 0,073 ± 0,026ac 0,000 ± 0,000c
22:6n-3 1,479 ± 0,077ab 2,835 ± 0,093a 2,915 ± 0,117b
24:1n-9 1,872 ± 0,190ab 0,737 ± 0,071ac 0,160 ± 0,024bc
Ʃ SFA 48,158 ± 1,776 48,229 ± 1,23 49,839 ± 1,498
Ʃ MUFA 40,653 ± 1,636ab 33,715 ± 1,303a 35,429 ± 1,032b
Ʃ PUFA 9,621 ± 0,343ab 16,711 ± 0,464ac 12,594 ± 0,465bc
Ʃ trans FA 1,569 ± 0,034ab 1,345 ± 0,108ac 2,138 ± 0,022bc
Ʃ Omega3 2,896 ± 0,153ab 5,552 ± 0,145ac 5,006 ± 0,157bc
Ʃ Omega5 0,047 ± 0,028 0,000 ± 0,000c 0,062 ± 0,006c
Ʃ Omega6 6,422 ± 0,208a 10,525 ± 0,555ac 6,584 ± 0,271c
Ʃ Omega7 12,709 ± 0,509a 10,358 ± 0,511ac 12,673 ± 0,435c
Table 3 Membrane fatty acid profiles of Jurkat, Raji and THP-1
cell lines (Continued)
Ʃ Omega9 28,199 ± 1,160ab 23,992 ± 0,959a 23,698 ± 0,648b
UI 73,097 ± 2,362ab 92,332 ± 1,687ac 83,240 ± 2,764bc
PI 43,162 ± 1,357ab 69,931 ± 1,054ac 62,191 ± 2,232bc
Data are expressed as mean (± SD) weight % of total membrane fatty acids
(n = 5). a, b, c Statistically significant difference (P < 0.05) as follows: a Jurkat vs
Raji, b Jurkat vs THP-1, c Raji vs THP-1
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Table 4 Comparison of membrane fatty acid profiles between immortalised cell lines and corresponding primary leukocyte classes
Jurkat CD4+ CD8+ Raji CD19+ THP1 CD14+
9:0 0,000 ± 0,000 0,000 ± 0,000 0,000 ± 0,000 0,046 ± 0,046 0,000 ± 0,000 0,000 ± 0,000 0,000 ± 0,000
12:0 0,056 ± 0,011 0,000 ± 0,000* 0,000 ± 0,000* 0,052 ± 0,015 0,000 ± 0,000* 0,041 ± 0,025 0,000 ± 0,000*
14:0 2,062 ± 0,085 0,635 ± 0,190* 0,870 ± 0,185* 1,647 ± 0,093 0,923 ± 0,215* 2,313 ± 0,493 0,413 ± 0,157*
14:1n-5 0,047 ± 0,028 0,000 ± 0,000* 0,000 ± 0,000* 0,000 ± 0,000 0,000 ± 0,000 0,041 ± 0,009 0,000 ± 0,000*
15:0 0,194 ± 0,012 0,256 ± 0,150* 0,412 ± 0,125* 0,526 ± 0,074 0,430 ± 0,139 0,324 ± 0,017 0,180 ± 0,107*
16:0 25,776 ± 2,014 27,156 ± 1,864 29,451 ± 2,352* 23,959 ± 1,124 31,780 ± 3,523* 28,591 ± 0,655 20,373 ± 2,321*
t16:1n-7 0,834 ± 0,036 0,265 ± 0,133* 0,364 ± 0,156* 1,345 ± 0,108 0,397 ± 0,171* 1,766 ± 0,074 0,203 ± 0,097*
16:1n-7 7,188 ± 0,407 0,257 ± 0,140* 0,341 ± 0,161* 1,656 ± 0,085 0,358 ± 0,174* 4,177 ± 0,195 0,255 ± 0,080*
17:0 0,411 ± 0,050 0,696 ± 0,169* 0,922 ± 0,258* 0,679 ± 0,071 0,879 ± 0,210 0,458 ± 0,076 0,435 ± 0,067
17:1n-7 0,000 ± 0,000 0,000 ± 0,000 0,000 ± 0,000 0,695 ± 0,050 0,000 ± 0,000* 0,436 ± 0,004 0,000 ± 0,000*
18:0 18,049 ± 0,606 26,877 ± 3,827* 28,296 ± 3,344* 20,329 ± 0,837 30,470 ± 4,447* 14,511 ± 0,640 24,146 ± 2,354*
t18:1n-9 0,735 ± 0,033 0,012 ± 0,033* 0,021 ± 0,060* 0,000 ± 0,000 0,020 ± 0,057 0,000 ± 0,000 0,039 ± 0,063
18:1n-9 24,938 ± 1,156 7,919 ± 1,053* 6,383 ± 1,044* 20,063 ± 0,945 7,083 ± 3,024* 22,967 ± 0,300 14,440 ± 1,039*
18:1n-7 5,521 ± 0,356 2,208 ± 0,375* 1,662 ± 0,424* 8,007 ± 0,437 1,431 ± 0,199* 7,906 ± 0,072 1,552 ± 0,225*
18:2n-6 3,144 ± 0,210 6,946 ± 1,323* 5,071 ± 0,803* 3,893 ± 0,115 4,705 ± 0,878 1,626 ± 0,161 6,577 ± 0,772*
18:3n-6 0,094 ± 0,017 0,179 ± 0,118 0,229 ± 0,138 0,045 ± 0,013 0,206 ± 0,183 0,037 ± 0,007 0,167 ± 0,091*
18:3n-3 0,302 ± 0,036 0,396 ± 0,319 0,601 ± 0,232* 0,324 ± 0,050 0,536 ± 0,280 0,130 ± 0,009 0,180 ± 0,090
20:0 0,608 ± 0,045 0,697 ± 0,241 1,096 ± 0,241* 0,421 ± 0,037 1,156 ± 0,215* 0,406 ± 0,026 0,533 ± 0,109
20:1n-9 0,942 ± 0,091 0,806 ± 0,475 1,141 ± 0,995 2,334 ± 0,091 0,896 ± 0,846* 0,572 ± 0,022 0,672 ± 0,249*
20:3n-9 0,302 ± 0,012 0,765 ± 0,090* 0,513 ± 0,116* 0,635 ± 0,066 0,608 ± 0,132 1,035 ± 0,033 0,618 ± 0,087*
20:3n-6 0,108 ± 0,007 1,519 ± 0,396* 1,009 ± 0,332* 1,222 ± 0,042 0,899 ± 0,318* 1,222 ± 0,030 1,357 ± 0,304*
20:4n-6 2,166 ± 0,109 12,755 ± 2,656* 9,251 ± 3,097* 4,347 ± 0,511 8,240 ± 4,173* 4,220 ± 0,060 16,422 ± 2,357*
20:3n-3 0,000 ± 0,000 0,041 ± 0,076 0,059 ± 0,119 0,097 ± 0,013 0,000 ± 0,000* 0,150 ± 0,015 0,025 ± 0,059*
20:5n-3 0,042 ± 0,013 0,098 ± 0,112 0,166 ± 0,301 0,572 ± 0,038 0,113 ± 0,165* 0,689 ± 0,017 0,138 ± 0,100*
22:0 0,946 ± 0,114 0,978 ± 0,579 1,642 ± 0,591* 0,409 ± 0,018 1,356 ± 0,435* 0,369 ± 0,085 0,492 ± 0,152
22:1n-9 0,144 ± 0,018 1,588 ± 0,595* 2,725 ± 1,570* 0,223 ± 0,024 2,014 ± 1,418* 0,067 ± 0,008 0,664 ± 0,430*
22:2n-6 0,000 ± 0,000 0,000 ± 0,000 0,024 ± 0,067 0,117 ± 0,018 0,000 ± 0,000* 0,074 ± 0,005 0,031 ± 0,045
23:0 0,056 ± 0,013 0,216 ± 0,277 0,239 ± 0,250 0,089 ± 0,015 0,087 ± 0,175 0,027 ± 0,013 0,057 ± 0,053
22:4n-6 0,747 ± 0,103 1,816 ± 0,314* 2,662 ± 1,945* 0,684 ± 0,092 1,545 ± 0,610* 0,278 ± 0,020 3,553 ± 0,446*
22:5n-6 0,164 ± 0,026 0,356 ± 0,110* 0,234 ± 0,189 0,216 ± 0,034 0,431 ± 0,754 0,296 ± 0,027 0,624 ± 0,227*
22:5n-3 1,074 ± 0,121 1,300 ± 0,444 0,855 ± 0,315 1,723 ± 0,069 0,726 ± 0,279* 1,653 ± 0,026 2,376 ± 0,445*
24:0 0,000 ± 0,000 0,557 ± 0,345* 0,809 ± 0,737* 0,073 ± 0,026 0,606 ± 0,292* 0,000 ± 0,000 0,307 ± 0,135*
22:6n-3 1,479 ± 0,077 2,672 ± 1,315 2,852 ± 2,253 2,835 ± 0,093 2,040 ± 1,799 3,481 ± 0,077 3,050 ± 1,187
24:1n-9 1,872 ± 0,190 0,035 ± 0,098* 0,098 ± 0,276* 0,737 ± 0,071 0,064 ± 0,180* 0,139 ± 0,017 0,123 ± 0,149
Ʃ SFA 48,158 ± 1,776 58,067 ± 5,419* 63,738 ± 5,544* 48,229 ± 1,230 67,687 ± 7,719* 47,040 ± 0,881 46,936 ± 4,789*
Ʃ MUFA 40,653 ± 1,636 12,812 ± 1,675* 12,351 ± 2,609* 33,715 ± 1,303 11,846 ± 3,172* 36,304 ± 0,505 17,705 ± 1,311*
Ʃ PUFA 9,621 ± 0,343 28,844 ± 4,890* 23,526 ± 4,114* 16,711 ± 0,464 20,049 ± 5,101* 14,890 ± 0,388 35,118 ± 3,867*
Ʃ trans FA 1,569 ± 0,034 0,276 ± 0,125* 0,385 ± 0,135* 1,345 ± 0,108 0,417 ± 0,172* 1,766 ± 0,074 0,241 ± 0,100*
Ʃ Omega3 2,896 ± 0,153 4,507 ± 1,587 4,533 ± 2,154 5,552 ± 0,145 3,415 ± 1,870 6,104 ± 0,126 5,770 ± 1,552
Ʃ Omega5 0,047 ± 0,028 0,000 ± 0,000* 0,000 ± 0,000* 0,000 ± 0,000 0,000 ± 0,000 0,041 ± 0,009 0,000 ± 0,000*
Ʃ Omega6 6,422 ± 0,208 23,572 ± 4,204* 18,481 ± 4,052* 10,525 ± 0,555 16,026 ± 5,418* 7,751 ± 0,274 28,730 ± 3,304*
Ʃ Omega7 12,709 ± 0,509 2,465 ± 0,376* 2,004 ± 0,477* 10,358 ± 0,511 1,789 ± 0,313* 12,519 ± 0,249 1,806 ± 0,291*
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arachidonic acid was significantly lower after stimulation
(Table 5).
Refeed® supplementation realigns Jurkat membrane fatty
acid composition to that of primary human CD4+
lymphocytes
Jurkat cells were cultured in the traditional medium
(RPMI + 10 % FBS) supplemented with specific Refeed®
supplements, which are completely defined combina-
tions of lipids and lipophilic antioxidants (see Methods).
Culture with Refeed® WT was able to modify and main-
tain over time the membrane fatty acid profile of Jurkat
cells to one that better matched that of primary CD4+
lymphocytes from healthy individuals (Table 6). In par-
ticular, linoleic and arachidonic acid proportions did not
differ from proportions seen in the fresh CD4+ cells
(Table 6). None of the ten summary parameters was dif-
ferent between primary CD4+ lymphocytes and Refeed®
WT supplemented Jurkat cells, while they were all differ-
ent between traditionally cultured Jurkat cells and pri-
mary CD4+ cells (Table 6). Therefore, the membrane
network of Refeed® WT supplemented Jurkat cells
mimics that of freshly isolated primary CD4+ lympho-
cytes in its fatty acid composition and so most likely in
its biophysical and functional properties.
Jurkat cells were also incubated with Refeed® CVD and
with Refeed® O3+ and were characterized by a fatty acid
composition very consistent over culture passages.
Figure 1 summarises the membrane fatty acid compos-
ition data for these cells as well as for fresh primary
CD4+ T lymphocytes, Jurkat cells cultured with standard
medium and Jurkat cells cultured with Refeed® WT. In-
cubation of Jurkat cells with Refeed® WT, Refeed® CVD
or Refeed® O3+ resulted in Jurkat cells with proportions
of saturated, monounsaturated, polyunsaturated, n-6
polyunsaturated and arachidonic acids that were similar
to those seen in fresh primary CD4+ T lymphocytes and
quite different from those seen normally in cultured
Jurkat cells (Fig. 1). Incubation with Refeed® CVD re-
sulted in Jurkat cells with an elevated proportion of trans
fatty acids and a decreased proportion of n-3 PUFAs in-
cluding docosahexaenoic acid (Fig. 1). Conversely incu-
bation with Refeed® O3+ resulted in Jurkat cells with
lower proportions of arachidonic acid and n-6 PUFAs
and higher proportions of docosahexaenoic acid and n-3
PUFAs (Fig. 1).
Discussion
Leucocytes are composed of different classes of cells, in-
cluding CD4+ T-lymphocytes, CD8+ T-lymphocytes, B
lymphocytes and monocytes; each cell class has specific
functions within the immune system. Numerous studies
have noted the importance of the membrane network
within specific leukocyte classes, highlighting how the
functional diversity of these cells is extremely refined
and very often linked to changes in the membrane fatty
acid profile, with consequences that affect membrane
biophysical properties. Nevertheless, the current litera-
ture lacks a systematic comparison between the main
leukocyte classes concerning their membrane fatty acid
composition. Here we identified marked differences in
membrane fatty acid composition among the four
leukocyte subclasses studied. In particular, monocytes
had quite a different membrane fatty acid profile from
lymphocytes. Furthermore, it is interesting that even
closely related cells such as CD4+ and CD8+ T-
lymphocytes are different from one another. The mem-
brane composition of the leukocytes was summarized
according to particular characteristics (e.g. UI) that
might be related to function, at least at the level of the
membrane. Indeed membrane-mediated events are able
to be modulated by changing the fatty acid composition
of the membrane, as clearly demonstrated for phagocyt-
osis [24, 29]. The four leukocyte classes studied differed
according to the summary characteristics, again with
monocytes being quite different from lymphocytes. Al-
though there are many reports of the fatty acid compos-
ition of specific leukocyte classes such as neutrophils
[30–33] and mononuclear cells [24, 34–37] very few
studies have made comparisons between different
leukocyte classes before. Perhaps the most detailed pre-
vious example is Gibney and Hunter [38] who compared
the fatty acid composition of human blood neutrophils,
T-lymphocytes, B-lymphocytes and monocytes. They
found differences amongst these four cell types, in gen-
eral agreement with the current study.
The second key finding of the current study is that the
membrane fatty acid composition is markedly different
Table 4 Comparison of membrane fatty acid profiles between immortalised cell lines and corresponding primary leukocyte classes
(Continued)
Ʃ Omega9 28,199 ± 1,160 11,112 ± 1,515* 10,861 ± 2,450* 23,992 ± 0,959 10,665 ± 3,083* 24,779 ± 0,333 16,516 ± 1,116*
UI 73,097 ± 2,362 109,691 ± 17,760* 92,754 ± 17,734* 92,332 ± 1,687 78,864 ± 20,728* 92,934 ± 1,835 141,417 ± 15,994*
PI 43,162 ± 1,357 91,565 ± 17,034* 79,091 ± 19,319* 69,931 ± 1,054 65,462 ± 16,533 73,093 ± 1,495 118,882 ± 15,487*
Membrane fatty acid profile of Jurkat, Raji and THP-1 cells compared to the membrane fatty acid profile of human leukocyte subclasses. Data are expressed in
weight % of total membrane fatty acids and presented as means ± SD (n = 5 for Jurkat,Raji and THP-1; n = 8 for CD4+, CD8, CD19+ and CD14+ * Statistically
significant difference (P < 0.05) from the respective immortalised cell line
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Table 5 Membrane fatty acid profile comparison between freshly isolated and primary lymphocytes
Freshly isolated lymphocytes Primary lymphocytes 96 h - non stimulated Primary lymphocytes 96 h - PHA stimulated
14:0 0,426 ± 0,024ab 0,678 ± 0,079ac 0,801 ± 0,062bc
15:0 0,196 ± 0,012ab 0,273 ± 0,058a 0,300 ± 0,055b
16:0 22,772 ± 1,171ab 28,499 ± 1,267ac 31,641 ± 1,304bc
t16:1n-7 0,261 ± 0,011 0,268 ± 0,028 0,316 ± 0,052
16:1n-7 0,281 ± 0,011ab 0,180 ± 0,011ac 0,233 ± 0,014bc
17:0 0,448 ± 0,025ab 0,717 ± 0,173a 0,770 ± 0,145b
17:1 0,065 ± 0,017ab 0,000 ± 0,000a 0,000 ± 0,000b
18:0 24,839 ± 1,710ab 30,630 ± 1,045a 32,467 ± 1,992b
t18:1n-9 0,000 ± 0,000 0,025 ± 0,049 0,041 ± 0,058
18:1n-9 15,653 ± 0,557ab 9,182 ± 0,084a 9,310 ± 0,882b
18:1n-7 2,076 ± 0,119ab 1,222 ± 0,027a 1,307 ± 0,209b
18:2n-6 6,512 ± 0,250ab 3,330 ± 0,085a 3,310 ± 0,231b
18:3n-6 0,077 ± 0,013ab 0,096 ± 0,006ac 0,130 ± 0,025bc
18:3n-3 0,117 ± 0,025a 0,254 ± 0,127a 0,255 ± 0,122
20:0 0,604 ± 0,040ab 1,106 ± 0,167a 1,153 ± 0,141b
20:1n-9 0,908 ± 0,073ab 0,517 ± 0,013a 0,524 ± 0,067b
20:3n-9 0,634 ± 0,036ab 0,333 ± 0,039a 0,402 ± 0,123b
20:3n-6 1,522 ± 0,083ab 1,137 ± 0,089a 1,024 ± 0,177b
20:4n-6 15,726 ± 0,900ab 12,940 ± 1,163ac 8,644 ± 1,592bc
20:5n-3 0,182 ± 0,018 0,227 ± 0,017c 0,170 ± 0,032c
22:0 0,301 ± 0,064ab 1,018 ± 0,371a 1,070 ± 0,441b
22:1n-9 0,082 ± 0,011ab 0,108 ± 0,015a 0,113 ± 0,023b
22:2n-6 0,080 ± 0,009b 0,117 ± 0,019c 0,000 ± 0,000bc
23:0 0,000 ± 0,000ab 0,167 ± 0,031a 0,185 ± 0,057b
22:4n-6 2,370 ± 0,104b 2,532 ± 0,294c 1,676 ± 0,303bc
22:5n-6 0,469 ± 0,075 0,686 ± 0,367 1,488 ± 2,231
22:5n-3 1,526 ± 0,076ab 1,558 ± 0,057ac 1,063 ± 0,174bc
22:6n-3 1,872 ± 0,094 2,197 ± 0,102c 1,606 ± 0,222c
Ʃ SFA 49,588 ± 1,998ab 63,089 ± 1,234ac 68,386 ± 2,794bc
Ʃ MUFA 19,065 ± 0,742ab 11,209 ± 0,068a 11,488 ± 1,106b
Ʃ PUFA 31,086 ± 1,268ab 25,409 ± 1,258ac 19,769 ± 2,124bc
Ʃ trans FA 0,261 ± 0,011 0,292 ± 0,072 0,357 ± 0,097
Ʃ Omega3 3,697 ± 0,187b 4,236 ± 0,133c 3,094 ± 0,342bc
Ʃ Omega5 0,000 ± 0,000 0,000 ± 0,000 0,000 ± 0,000
Ʃ Omega6 26,756 ± 1,112ab 20,839 ± 1,209ac 16,272 ± 1,925bc
Ʃ Omega7 2,422 ± 0,129ab 1,402 ± 0,018a 1,540 ± 0,220b
Ʃ Omega9 17,276 ± 0,657ab 10,141 ± 0,069a 10,350 ± 0,928b
UI 124,585 ± 5,279ab 101,606 ± 4,870ac 80,302 ± 9,028bc
PI 98,379 ± 3,877ab 88,712 ± 4,192a 69,943 ± 11,107b
Membrane fatty acid profile of freshly isolated lymphocytes compared to the membrane fatty acid profile of primary lymphocytes isolated, non-stimulated/
PHA-stimulated and cultivated in vitro for 96 h. Data are expressed in weight % of total membrane fatty acids and presented as means ± SD (n = 5 for all).
a, b, c Statistically significant difference (P < 0,05) as follows: a Freshly vs Non stimulated, b Freshly vs PHA-Stimulated, c Non stimulated vs PHA-Stimulated
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between fresh primary human leukocytes and compara-
tor immortalized cell lines that are commonly used in
research. This would suggest that the cell lines as cur-
rently cultured may not represent an optimal situation
with which to make conclusions about in vivo or physio-
logical processes. All three immortalized cell lines were
characterised by a significant deficit of PUFAs and n-6
PUFAs, in particular of arachidonic acid, a biologically
important fatty acid from which over one hundred bio-
active lipids can be formed. The membrane fatty acid
profile of all three cell lines was very consistent over sev-
eral in vitro passages (data not shown). An interesting
observation was that the membrane fatty acid profiles of
the three cell lines were rather different from one an-
other, even though the cells were grown in exactly the
same culture medium and with the same batch of FBS.
This observation shows the cells are able to control their
membrane fatty acid composition suggesting metabolic
and/or genetic mechanisms as being responsible. Never-
theless it is known that adding specific fatty acids to the
culture medium can modify the membrane fatty acid
composition of cultured primary leukocytes [29, 39] and
cultured leukocytic cell lines [40, 41]. Indeed in the
current study it was observed that adding mixtures of
fatty acids to Jurkat cells resulted in an altered mem-
brane fatty acid composition. By tailoring the fatty acid
mixture added to the medium, Jurkat cells could be pro-
duced that had a membrane fatty acid profile more
closely resembling that of fresh primary human T-
lymphocytes. Other fatty acid mixtures produced Jurkat
cells enriched in n-3 PUFAs, perhaps mimicking fish oil
supplementation, or enriched in trans fatty acids. These
modifications may enable the development of innovative
experimental models that can mimic specific physio-
logical or pathological conditions, or even the membrane
conditions of specific human populations and/or deriv-
ing from specific dietary intakes. This would represent a
significant advance in experimental capabilities.
The final key finding of the current study is that after
four days of cultivation in vitro, primary lymphocytes
showed membrane fatty acid profiles which were very
Table 6 Effect of lipid supplementation on membrane fatty
acid profile of Jurkat cells
CD4+ Jurkat Jurkat + Refeed WT
12:0 0,000 ± 0,000 0,056 ± 0,011* 0,000 ± 0,000
14:0 0,635 ± 0,190 2,062 ± 0,085* 0,829 ± 0,155
14:1n-5 0,000 ± 0,000 0,047 ± 0,028* 0,000 ± 0,000
15:0 0,256 ± 0,150 0,194 ± 0,012* 0,172 ± 0,094
16:0 27,156 ± 1,864 25,776 ± 2,014 21,420 ± 2,863*
t16:1n-7 0,265 ± 0,133 0,834 ± 0,036* 0,236 ± 0,084
16:1n-7 0,257 ± 0,140 7,188 ± 0,407* 0,422 ± 0,229
17:0 0,696 ± 0,169 0,411 ± 0,050* 0,650 ± 0,299
18:0 26,877 ± 3,827 18,049 ± 0,606* 29,737 ± 2,063
t18:1n-9 0,012 ± 0,033 0,735 ± 0,033* 0,089 ± 0,142
18:1n-9 7,919 ± 1,053 24,938 ± 1,156* 11,018 ± 1,526*
18:1n-7 2,208 ± 0,375 5,521 ± 0,356* 2,104 ± 0,851
18:2n-6 6,946 ± 1,323 3,144 ± 0,210* 7,446 ± 1,034
18:3n-6 0,179 ± 0,118 0,094 ± 0,017 0,235 ± 0,132
18:3n-3 0,396 ± 0,319 0,302 ± 0,036 0,296 ± 0,101
20:0 0,697 ± 0,241 0,608 ± 0,045 0,753 ± 0,377
20:1n-9 0,806 ± 0,475 0,942 ± 0,091 0,634 ± 0,231
20:3n-9 0,765 ± 0,090 0,302 ± 0,012* 0,757 ± 0,091
20:3n-6 1,519 ± 0,396 0,108 ± 0,007* 2,110 ± 0,592
20:4n-6 12,755 ± 2,656 2,166 ± 0,109* 12,296 ± 1,326
20:3n-3 0,041 ± 0,076 0,000 ± 0,000 0,004 ± 0,009
20:5n-3 0,098 ± 0,112 0,042 ± 0,013 0,133 ± 0,114
22:0 0,978 ± 0,579 0,946 ± 0,114 0,448 ± 0,168*
22:1n-9 1,588 ± 0,595 0,144 ± 0,018* 0,081 ± 0,021*
22:2n-6 0,000 ± 0,000 0,000 ± 0,000 0,000 ± 0,000
23:0 0,216 ± 0,277 0,056 ± 0,013 0,258 ± 0,197
22:4n-6 1,816 ± 0,314 0,747 ± 0,103* 4,457 ± 0,385*
22:5n-6 0,356 ± 0,110 0,164 ± 0,026* 0,262 ± 0,068
22:5n-3 1,300 ± 0,444 1,074 ± 0,121 0,670 ± 0,072*
24:0 0,557 ± 0,345 0,000 ± 0,000* 0,069 ± 0,012*
22:6n-3 2,672 ± 1,315 1,479 ± 0,077 2,413 ± 1,232
24:1n-9 0,035 ± 0,098 1,872 ± 0,190* 0,000 ± 0,000
Ʃ SFA 58,067 ± 5,419 48,158 ± 1,776* 54,337 ± 2,323
Ʃ MUFA 12,812 ± 1,675 40,653 ± 1,636* 14,259 ± 1,005
Ʃ PUFA 28,844 ± 4,890 9,621 ± 0,343* 31,078 ± 2,759
Ʃ trans FA 0,276 ± 0,125 1,569 ± 0,034* 0,326 ± 0,180
Ʃ Omega3 4,507 ± 1,587 2,896 ± 0,153 3,516 ± 1,119
Ʃ Omega5 0,000 ± 0,000 0,047 ± 0,028* 0,000 ± 0,000
Ʃ Omega6 23,572 ± 4,204 6,422 ± 0,208* 26,806 ± 2,474
Ʃ Omega7 2,465 ± 0,376 12,709 ± 0,509* 2,526 ± 0,911
Table 6 Effect of lipid supplementation on membrane fatty
acid profile of Jurkat cells (Continued)
Ʃ Omega9 11,112 ± 1,515 28,199 ± 1,160* 12,489 ± 1,447
UI 109,691 ± 17,760 73,097 ± 2,362* 126,496 ± 10,755
PI 91,565 ± 17,034 43,162 ± 1,357* 93,767 ± 11,347
Membrane fatty acid profile of fresh CD4+ human T lymphocytes compared to
the membrane fatty acid profile of traditionally cultured Jurkat cells and the
membrane fatty acid profile of Refeed® WT supplemented Jurkat cells. Data
are expressed in weight % of total membrane fatty acids and presented as
means ± SD (n = 8 for CD4+, n = 5 for traditionally cultured Jurkat cells, n = 5
for Refeed® WT supplemented Jurkat cells). * Statistically significant
difference (P < 0.05)
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different from the original freshly prepared cells, and the
changes were in line with what was already observed for
immortalized cells. In particular, there was a decrease of
PUFA, of n-6 PUFA and of arachidonic acid, and so
likely a decrease in membrane fluidity. Membranes of
lymphocytes cultured for 96 h showed a 50 % lower con-
tent of linoleic acid and an 18 % lower content of arachi-
donic acid compared with fresh cells. The decreased
content of arachidonic acid was exaggerated by mitogen
stimulation (45 % lower content than fresh cells). Anel
et al. [42] reported effects of quiescent and mitogen-
stimulated culture for 72 h on the fatty acid composition
of human mononuclear cells and purified T-lymphocytes.
They identified that culture resulted in lower contents of
both linoleic and arachidonic acid (30 % and 19 %, re-
spectively) in purified T-lymphocytes, changes that were
exaggerated by mitogenic stimulation. Likewise, Calder
et al. [39] reported that culture of mitogen-stimulated rat
lymphocytes for 48 h resulted in lower contents of linoleic
and arachidonic acids (45 % and 25 % lower respectively)
than seen in freshly prepared cells. These changes in fatty
acid composition were associated with changes in mem-
brane fluidity and T-lymphocyte function [39, 42], estab-
lishing a clear link between membrane fatty acid content,
membrane physical properties and leukocyte function
[25]. Thus, it is likely that the differences in leukocyte
membrane fatty acid content reported in the current study
have a functional significance.
The findings of the current study suggest that the clas-
sical method of in vitro cultivation of leukocytes is not
optimal, when the membrane, its fatty acid content and
its biophysical properties are taken into consideration. It
is evident that comparison of fresh primary cells with
those produced in vitro and the development of custom-
ized in vitro supplementation to mimic different nutri-
tional, physiological and pathological contexts should
become more routine practice when using these cell
lines. If not, it seems highly likely that the large in vivo
versus in vitro difference is likely to lead to highly biased
experimental data.
The use of customized lipid supplementation may rep-
resent an important tool to evolve in vitro experimental
Fig. 1 Comparison of main fatty acid membrane parameters of in-vivo and in-vitro leukocytes. The main fatty acid parameters characterizing the
membrane fatty acid profile of CD4+ (primary fresh uncultured CD4+ T lymphocytes), JC (Jurkat cells cultured under traditional conditions),
WT (Jurkat cells supplemented with Refeed® WT), CVD (Jurkat cells supplemented with Refeed® CVD), O3+ (Jurkat cells supplemented with
Refeed® O3+). Data are expressed as % of controls (CD4+) and presented as means ± SD (n = 8 for CD4+, n = 5 for JC, WT, CVD, O3+). * Statistically
significant difference (P < 0.05)
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models. By changing the quality and quantity of the
components of the supplement in order to act on spe-
cific pathways of synthesis and control of the lipid me-
tabolism, it is possible to produce cell membranes with a
very different fatty acid profile, perhaps representing dif-
ferent in vivo nutritional exposures, and even typical of
specific physiological and pathological conditions.
Conclusions
The present study shows that the various classes of leu-
kocytes have a specific membrane fatty acid profile
in vivo that is unlike that of other leukocytes, and which
makes the membrane properties of different cell types
different and probably better aligned with their function.
However, the specific characteristics of the membrane
are completely lost during the in vitro cultivation of pri-
mary leukocytes. Furthermore primary leukocytes have
very different membrane fatty acid compositions from
commonly studied comparator immortalized cell lines.
This in vivo versus in vitro membrane dichotomy makes
the currently used in vitro experimental models inad-
equate. Culture of primary lymphocytes results in
changes in fatty acid composition. Addition of specific
mixtures of fatty acids to the culture medium can be
used to modify the fatty acid composition of immortal-
ized cell lines (in this case Jurkat cells) to much better
resemble that of freshly prepared human blood lympho-
cytes. Such customised lipid preparations can be used to
improve in vitro research with immortalised leukocytic
cell lines. The development of customised lipid supple-
ments can greatly aid the development of innovative ex-
perimental models that can mimic specific physiological
or pathological conditions, or even the membrane con-
ditions of specific human populations and/or deriving
from specific dietary intakes, thus expanding the quality
of in vitro studies and guaranteeing the availability of
better quality experimental data for scientific research
and for the development of new drugs and innovative
therapies.
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